The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial
Frederich Robert, Mcneill Robert, Berglind Niklas, Fleming Douglas, Chen, Chen Roland